Urine excretion of a monocytic chemotaxic protein-1 and a transforming growth factor beta1 as an indicator of chronic glomerulonephritis progression

Terapevticheskii Arkhiv

Volumn 78, Issue 5, 2006, Pages 9-14

  Bobkova, I N ^a   Chebotareva, N V ^a   Kozlovskaya, L V ^a   Varshavsky, V A ^a   Golitsyna, E P ^a  

^a NONE

Author keywords

Chronic glomerulonephritis; Interstitial fibrosis; Monocytic chemotaxic protein 1; Transforming growth factor beta1; Urine excretion

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOPSY; CHRONIC DISEASE; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULONEPHRITIS; HOSPITALIZATION; HUMAN; KIDNEY; MALE; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; URINE;

ADOLESCENT; ADULT; AGED; BIOPSY; CHEMOKINE CCL2; CHRONIC DISEASE; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULONEPHRITIS; HUMANS; KIDNEY; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33745416599     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Eddy A. A. Proteinuria and interstitial injury. Nephrol. Dial. Transplant. 2004; 19: 277-281.
2. Bohle A., Muller G. A., Wehrmann W. et al. Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies and chronic interstitial nephritides. Kidney Int. 1996; 54: 2-9.
3. Bottinger E. P., Bitzer M. TGF-β signaling in renal disease. J. Am. Soc. Nephrol. 2002; 13: 2600-2610.
4. Schneider A., Panzer U., Zahner G. et al. Monocyte chemoattractant protein-1 mediates collagen deposition in experimental glomerulonephritis by transforming growth factor-beta. Kidney Int. 1999; 56 (1): 135-144.
5. Wada T., Yokoyama H., Kobayashi K. Chemokines: new target molecules in renal diseases. Clin. Exp. Nephrol. 2000; 4: 273-280.
6. Honkanen E., Teppo A., Tornroth T. et al. Urinary transforming growth factor-beta 1 in membranous glomerulonephritis. Nephrol. Dial. Transplant. 1997; 12 (12): 2562-2568.
7. Wada T., Yokoyama H., Su S. et al. Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis. Kidney Int. 1996; 49: 761-767.
8. Tesch G. H., Schwarting A., Kinoshita K. et al. Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis. J. Clin. Invest. 1999; 103 (1): 73-80.
9. Remuzzi G., Bertani T. Pathophysiology of progressive nephropathies. N. Engl. J. Med. 1998; 339 (20): 1448-1456.
10. Burton C. J., Combe C., Walls J., Harris K. P. G. Secretion of chemokines and cytokines by tubular epithelial cells in response to proteins. Nephrol. Dial. Transplant. 1999; 14: 2628-2633.
11. Tam F. W. K., Sanders J.-S., George A. et al. Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis. Nephrol. Dial. Transplant. 2004; 19: 2761-2768.
12. Cockwell P., Howie A. J., Adu D. et al. In situ analysis of C-C chemokine mRNA in human glomerulonephritis. Kidney Int. 1998; 54 (3): 827.
13. Fan J. M., Ng Y. Y., Hill P. A. et al. Transforming growth factor beta regulates tubular epithelial-myofibroblasts transdifferentiation in vitro. Kidney Int. 1999; 56 (4): 1455-1467.
14. Border W. A., Okuda S., Languino L. R. et al. Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 1990; 346: 371-374.
15. Negri A. L. Prevention of progressive fibrosis in chronic renal diseases: Antifibritic agents. J. Nephrol. 2004; 17 (4): 496-503.